| Mitochondria in cancer D Grasso, LX Zampieri, T Capelôa, JA Van de Velde, P Sonveaux Cell stress 4 (6), 114, 2020 | 165 | 2020 |
| MitoQ inhibits human breast cancer cell migration, invasion and clonogenicity T Capeloa, J Krzystyniak, D d’Hose, A Canas Rodriguez, VL Payen, ... Cancers 14 (6), 1516, 2022 | 17 | 2022 |
| Inhibition of mitochondrial redox signaling with MitoQ prevents metastasis of human pancreatic cancer in mice T Capeloa, JA Van de Velde, D d’Hose, SG Lipari, F Derouane, ... Cancers 14 (19), 4918, 2022 | 14 | 2022 |
| Mitochondrial protein Cox7b is a metabolic sensor driving brain-specific metastasis of human breast cancer cells MCNM Blackman, T Capeloa, JD Rondeau, LX Zampieri, Z Benyahia, ... Cancers 14 (18), 4371, 2022 | 6 | 2022 |
| Why PhD students in Flanders consider quitting their PhD J Van de Velde, K Levecque, A Mortier, A De Beuckelaer ECOOM BRIEFS, 1-5, 2019 | 5 | 2019 |
| Waarom doctorandi in Vlaanderen denken aan stoppen met doctoreren J Van de Velde, K Levecque, A Mortier, A De Beuckelaer ECOOM BRIEFS, 2019 | 4 | 2019 |
| Doing what matters in times of stress: No-nonsense meditation and occupational well-being in COVID-19 J Van de Velde, K Levecque, B Weijters, S Laureys Plos one 18 (11), e0292406, 2023 | 1 | 2023 |
| How often do PhD students consider quitting their PhD? Findings for Flanders 2013-2018 K Levecque, J Van de Velde, A De Beuckelaer, A Mortier ECOOM BRIEFS, 1-5, 2019 | 1 | 2019 |
| Correction: Doing what matters in times of stress: No-nonsense meditation and occupational well-being in COVID-19 J Van de Velde, K Levecque, B Weijters, S Laureys PloS one 19 (6), e0305180, 2024 | | 2024 |
| Stem cells with brain tropism P Sonveaux, M Blackman, M Bedin, J Rondeau, TI De Miranda Capeloa, ... | | 2022 |
| Project ‘Wel in je Vel’: meditatie in tijden van COVID-19-pandemie: onderzoeksrapport welzijnseffecten bij leraren J Van de Velde, K Levecque, M Valcke | | 2022 |
| Hoe vaak denken doctorandi aan stoppen met onderzoek? Bevindingen voor Vlaanderen 2013-2018 K Levecque, J Van de Velde, A De Beuckelaer, A Mortier ECOOM BRIEFS, 2019 | | 2019 |
| Les cellules CAR-T: une innovation thérapeutique, mais à quel prix? Etude du tisagenlecleucel (Kymriah™), première thérapie basée sur les cellules CAR-T approuvée par la FDA … J Van de Velde, JB Demoulin | | |
